{
    "2019-10-31": [
        [
            {
                "time": "2018-10-31",
                "original_text": "格隆汇港股聚焦(10.31)︱中国建材前三季净利润升36%至104.28亿元 中国光大控股：部分高管已认购可购买公司股份的基金",
                "features": {
                    "keywords": [
                        "中国建材",
                        "净利润",
                        "增长",
                        "光大控股",
                        "高管认购"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "建筑材料",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "复星医药前三季度营收增17% 扣非后净增8%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "营收增长",
                        "净利润增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "复星医药：控股子公司获药品临床试验申请受理",
                "features": {
                    "keywords": [
                        "复星医药",
                        "临床试验",
                        "药品"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "复星医药：注射用曲妥珠单抗用于转移性乳腺癌适应症治疗的III期临床研究已达到预设的主要终点",
                "features": {
                    "keywords": [
                        "复星医药",
                        "曲妥珠单抗",
                        "乳腺癌",
                        "临床研究"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "一致性评价最新进展：受理号达1536个 35个品种过评已满3家",
                "features": {
                    "keywords": [
                        "一致性评价",
                        "药品审批",
                        "进展"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "带量采购倒逼制药企业创新，七成企业三季报增加研发费用",
                "features": {
                    "keywords": [
                        "带量采购",
                        "制药企业",
                        "研发费用",
                        "创新"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "【异动股】青蒿素板块拉升，海正药业(600267-CN)涨8.11%",
                "features": {
                    "keywords": [
                        "青蒿素",
                        "海正药业",
                        "股价上涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-31",
                "original_text": "医药股领涨，三季报业绩亮眼，哪些低估值高业绩标的值得关注？",
                "features": {
                    "keywords": [
                        "医药股",
                        "三季报",
                        "业绩增长",
                        "低估值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}